Reparel Knee Sleeve vs. TED Hose for Post-Op Recovery After Knee Surgery

No longer recruiting at 4 trial locations
ZL
RA
Overseen ByRachael A Kilkenny, MBA, BSN-RN
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University Hospitals Cleveland Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new method to aid recovery after knee replacement surgery. It compares a special knee sleeve, the Non-compressive Bioactive Garment, which uses infrared waves to reduce pain and swelling, with the usual tight socks (TED hose) that help with swelling and blood clots. The goal is to determine if the new sleeve can make recovery more comfortable and effective. Individuals who have had a single knee replaced and do not have conditions like rheumatoid arthritis or leg swelling problems may be suitable for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative recovery methods and enhance future patient care.

Do I need to stop my current medications for this trial?

The trial protocol does not specify if you need to stop taking your current medications. However, if you have a history of chronic narcotic use, you are excluded from participating.

What prior data suggests that the Reparel Knee Sleeve and TED Hose are safe for post-op recovery after knee surgery?

Research shows that the Non-Compressive Bioactive Garment (NCBG), such as the Reparel Knee Sleeve, is generally well-received by patients. Studies indicate it reduces pain and swelling after knee surgeries without causing major side effects. The garment reflects infrared waves back into the body, aiding recovery.

Previous research on patients with knee osteoarthritis suggests that the sleeve improves symptoms and overall function. These findings indicate the garment might be safe and effective for those recovering from knee surgery. Although no serious side effects have been reported, further research is needed to confirm these results for everyone.12345

Why are researchers excited about this trial?

Unlike the standard of care, which typically involves compression stockings like TED hose to manage post-op recovery after knee surgery, the non-compressive bioactive garment offers a unique approach. This garment reflects infrared waves generated by the body back into the soft tissue, potentially reducing pain and swelling without the need for compression. Researchers are excited about this treatment because it introduces a non-compressive method, which could offer a more comfortable recovery experience while still addressing inflammation and discomfort.

What evidence suggests that these treatments could be effective for post-op recovery after knee surgery?

Research shows that the Non-Compressive Bioactive Garment (NCBG), a treatment under study in this trial, can help reduce pain and swelling. Studies with similar bioactive sleeves have shown improvements in pain and movement for people with knee problems. For example, one study found that these garments reduced pain and improved movement in individuals with knee osteoarthritis. Another study demonstrated that bioactive sleeves effectively eased symptoms in conditions like tendinopathy, a painful tendon issue. These findings suggest that NCBG might relieve pain and aid recovery after knee surgery by reflecting infrared waves back into the surrounding tissue.14567

Who Is on the Research Team?

RA

Rachael A Kilkenney, MBA,BSN

Principal Investigator

University Hospitals

Are You a Good Fit for This Trial?

This trial is for individuals who have had a total knee replacement due to osteoarthritis. They must be able to follow post-op and rehab protocols, without a history of deep vein thrombosis (DVT), vascular bypass surgery on the operative limb, lymphedema, chronic narcotic use, or leg circumference over 23 inches. Those with primary inflammatory arthritis or allergies to silicone/polyester cannot join.

Inclusion Criteria

I had a knee replacement with specific design features.

Exclusion Criteria

Allergy to silicone/polyester
I cannot follow the required after-surgery care and rehab plans.
I have been diagnosed with a type of inflammatory arthritis, such as rheumatoid arthritis.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Pre-operative

Patients are recruited and consented in the office setting after non-operative modalities have been exhausted

1-2 weeks
1 visit (in-person)

Surgery and Immediate Post-operative

Patients undergo total knee arthroplasty and initial post-operative measurements are taken

1 day
1 visit (in-person)

Post-operative Treatment

Patients wear the assigned garment and track pain and narcotic use for 6 weeks

6 weeks
Daily self-reporting

Follow-up

Final range of motion and circumference measurements are obtained, and patients complete the Knee Society Score questionnaire

6 weeks
Regular intervals (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Non-compressive Bioactive Garment
  • Thrombo-Embolic-Deterrent
Trial Overview The study compares two methods for managing post-operative symptoms after knee replacement: a Non-Compressive Bioactive Garment (NCBG) versus standard compression stockings (TED hose). It will assess which is better at reducing pain, swelling, range of motion limitations and the need for narcotics.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Non-compressive Bioactive GarmentExperimental Treatment1 Intervention
Group II: Thrombo-Embolic DeterrentActive Control1 Intervention

Non-compressive Bioactive Garment is already approved in United States, Canada for the following indications:

🇺🇸
Approved in United States as Reparel Knee Sleeve for:
🇨🇦
Approved in Canada as Reparel Knee Sleeve for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University Hospitals Cleveland Medical Center

Lead Sponsor

Trials
348
Recruited
394,000+

Published Research Related to This Trial

Covalent Bruton tyrosine kinase (BTK) inhibitors are effective treatments for relapsed mantle cell lymphoma (MCL), but patients may develop resistance, necessitating alternative therapies.
Recent advancements include anti-CD19 chimeric antigen receptor T-cell therapy and novel treatments like noncovalent BTK inhibitors and bispecific antibodies, providing new options for patients who progress after BTK inhibitor therapy.
Therapeutic options for relapsed/refractory mantle cell lymphoma.Eyre, TA., Cheah, CY., Wang, ML.[2023]
In a study involving 20 patients with relapsed grade II non-Hodgkin's lymphoma, the combination treatment of vindesine, etoposide, and prednisolone (VEP) resulted in a 40% overall response rate, with 20% achieving complete responses lasting 9 to 13+ months.
The treatment was associated with manageable side effects, primarily alopecia and myelosuppression, indicating that VEP is an effective second-line option for patients who have not responded to first-line therapies.
Vindesine, etoposide (VP-16), and prednisolone (VEP) in relapsed patients with grade II non-Hodgkin's lymphoma.Hancock, BW.[2013]
Romidepsin, a histone deacetylase inhibitor, has shown clinical efficacy in treating adult patients with cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL), with overall response rates of 34% for CTCL and 38% for PTCL in phase II trials involving patients with relapsed or refractory disease.
The treatment is generally well-tolerated, although it can cause significant hematological side effects such as leukopenia and thrombocytopenia, indicating that while effective, monitoring for these adverse events is important during therapy.
Romidepsin: in the treatment of T-cell lymphoma.Yang, LP.[2021]

Citations

Reparel Knee Sleeve vs. TED Hose for Post-op Swelling ...This prospective study will evaluate pain, swelling, ROM as well as narcotic use in post-operative total knee arthroplasty patients using novel ...
Bioactive Knee Sleeve for Osteoarthritis: A Small Cohort ...Conclusions: These data suggest that a bioactive sleeve may improve patient-reported pain, symptoms, and function in the setting of knee. OA. Further research ...
Investigating the Efficacy of Bioactive Sleeves with Embedded ...The results of our study indicate that application of bioactive nano-semiconductor sleeves had a significant effect in alleviating Achilles tendinopathy.
Reparel™ Knee Sleeve for OsteoarthritisThis trial is testing a special knee brace called the Reparel™ knee sleeve, which uses heat to help reduce pain and improve movement in people with knee ...
Effects of Reparel™ Knee Sleeve on Knee OsteoarthritisThis investigation will examine this non-operative treatment modality and study it effect for the treatment of knee OA specifically by investigating the Reparel ...
Knee Sleeve – Arthritis Pain Relief & Post-Op RecoveryReparel Knee Sleeve reduces arthritis pain, post-surgical swelling, and inflammation. Clinically backed, non-pharma recovery support for active patients.
7.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/36191914/
Bioactive Knee Sleeve for Osteoarthritis: A Small Cohort ...Conclusions: These data suggest that a bioactive sleeve may improve patient-reported pain, symptoms, and function in the setting of knee OA. Further research is ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security